Skip to main content

Company
History

Leadership

Clients and Collaborators

By the Numbers
Capabilities
Emmes - CRO

Specialties

Vaccines & Infectious Diseases

Ophthalmology

Clinical Neuroscience

Rare Disease

Cell & Gene Therapy

Government

Additional Specialties

Hematology

Oncology

Maternal & Child Health

Medical Devices

Clinical Services

Biostatistics

Clinical Data Management

Clinical Research Services

Clinical Trial Management

Global Regulatory Affairs

Pharmacovigilance & Medical Monitoring

Veridix - Tech & AI

eClinical Platform

EDC

Decentralized Clinical Trials

RTSM

eCOA / ePRO

AI Agents

Biostats and Analysis Agent

Data Management Agent

Document Authoring

GlobalTrace

Analytics & Reporting

Clinical Pipelines

VERA
Resources
Newsroom

Blog
Careers
Contact
Locations

Contact Us

Breadcrumb

Emmes Group
Publications
Conversion To Tacrolimus To Ameliorate Cyclosporine Toxicities.

Publications

Submitted by ctuttle on Thu, 05/29/2025 - 08:29

Go back to Resources

Conversion to tacrolimus to ameliorate cyclosporine toxicities.

1997

Journal Article

Authors:

R, A.

Go back to Resources

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation

Company
Capabilities
- Emmes - CRO
- Veridix - Tech & AI
Resources
- Newsroom
- Blog
Careers
Contact
- Locations
- Contact Us

Copyright ©, The Emmes Company, LLC

Footer

Cookie Policy
External Privacy Notice
FCOI
Emmes EU-U.S. Data Privacy Framework
Purchasing Terms and Conditions